OvaScience Obtains $2,232,324 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    800 Boylston Street Boston, MA 02199
  • Company Description
    The company is applying innovative science to improve the quality of eggs (oocytes) and increase the success of in vitro fertilization (IVF). OvaScience’s proprietary technology, exclusively licensed from Harvard Medical School and Massachusetts General Hospital, enables the use of a women’s own cellular energy to improve egg quality.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.